1 not yet recruiting, 1 recruiting. 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Medium Vessel Occlusion Stroke (MeVO): new trials by email Literature Review of Medium Vessel Occlusion Stroke (MeVO) trials Research Report on Medium Vessel Occlusion Stroke (MeVO)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravenous Thrombolysis, Endovascular Treatment, or Bridging Therapy for Medium Vessel Occlusion Stroke Within 24 Hours Tenecteplase, Endovascular Treatment - Medium Vessel Occlusion Stroke (MeVO), Acute Ischemic Stroke | Phase 3 | Not yet recruiting | The First Affiliated Hospital of University of Science and Technology of China | 1395 | 2026-12-01 | 2026-11-12 |
| SAIL-MEVO: Endovascular Treatment Versus Best Medical Therapy for Distal Vessel Occlusions best medical therapy, Endovascular Treatment - Medium Vessel Occlusion Stroke (MeVO), Stroke Acute | Not applicable | Recruiting | Hospital Universitari Vall d'Hebron Research Institute | 420 | 2026-11-01 | 2026-11-04 |
Ischemic Stroke (2) · Stroke (1)
Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Nervous System Diseases (2) · Vascular Diseases (2) · Stroke (1)
Tenecteplase (1)
Hospital Universitari Vall d'Hebron Research Institute (1) · The First Affiliated Hospital of University of Science and Technology of China (1)
China (1) · Spain (1)
Wei Hu, MD, PhD (1)